The global genitourinary prosthetics market is expected to accumulate USD 577.9 million in value by 2023 end. During the forecast period ranging from 2023 to 2033, a CAGR worth 4.8% has been projected for the market, with an expected closing value worth USD 924.8 million by 2033. During 2018 to 2022 historical period, the industry grew at a value CAGR worth 3.5%.
The mounting availability of advanced materials for manufacturing prosthetic devices in developed countries like the USA & Germany and the growing risk factors associated with the onset of chronic infectious diseases boost the demand for genitourinary prosthetics.
| Attributes | Details |
|---|---|
| Historical Value (2022) | USD 556.7 million |
| Current Year Value (2023) | USD 577.9 million |
| Expected Forecast Value (2033) | USD 924.8 million |
| Projected CAGR (2023 to 2033) | 4.8% |
| Global Genitourinary Prosthetics Market Attraction | Consistent innovation in prosthetics technology, the availability of advanced materials for manufacturing prosthetic devices such as low-temperature polyethylene terephthalate (LPET), polyetheretherketone (PEEK), silicon, and the growing global adoption of these medical devices to unlock new growth opportunities. |
In general, a prosthesis is an artificial medical device used to replace any defective pieces that may have ended up lost due to trauma, congenital conditions, or infectious disease. Prosthetists or a team of healthcare experts, typically including surgeons, physical therapists, psychiatrists, and occupational therapists, collaborate to provide smooth services in prosthetic amputee rehabilitation.
The genitourinary system in the human body consists of the reproductive system and the urinary system, which are placed adjacent to each other and share common pathways. Many disorders affect the genitourinary system, most of which are caused by infectious diseases, disease conditions in the urinary structure, congenital anomalies, or trauma.
Genitourinary prosthetics are preoccupied with the diagnosis and treatment of diseases affecting the urinary tract including the male or female genital tract. Urinary incontinence is treated with genitourinary prosthetics, which come in three varieties: prosthetic devices, prosthetic implants, and genitourinary prosthetic grafts.
A genitourinary prosthetic implant is a medical device that replaces or supports a biological structure in the body that is missing or damaged. Depending on the needs of occupational therapists or prosthetists, they are made of silicon, titanium, or apatite. The genitourinary prosthetics market has recently been segmented based on the material used to manufacture prosthetics, which are silicon, titanium, and apatite.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Consistent innovation in prosthetics technology, the availability of advanced materials for manufacturing prosthetic devices such as low-temperature polyethylene terephthalate (LPET), polyetheretherketone (PEEK), silicon, and the growing global adoption of these medical devices are some of the major growth drivers of the genitourinary prosthetics market.
Hormonal and physical changes, type 2 diabetes, atherosclerosis, chronic kidney disease, Peyronie's disease, bladder cancer surgery, and other risk factors are among them. The genitourinary prosthetics market is expanding rapidly the growing prevalence of risk factors associated with erectile dysfunction.
The global market for genitourinary prosthetics is expanding as more women and men perceive urinary conditions that can be adequately controlled with genitourinary prosthetics. The genitourinary prosthetics market includes testicular prosthetics, artificial urinary sphincters, and penile prosthetics.
The rise in risk factors associated with the onset of chronic infectious diseases, as well as the growing preference of women and men for treatment of genitourinary conditions, combined with an increase in patient awareness of genitourinary prosthetics, is dominating the development genitourinary prosthetics market.
However, low reimbursement cuts for genitourinary prosthetics and high costs for advanced technology are expected to limit the growth of the genitourinary prosthetics market.
Principal Consultant
North America dominates the global genitourinary prosthetics market in terms of revenue, followed by Europe, owing to rising demand for genitourinary prosthetics and the adoption of advanced technology in genitourinary prosthetic devices. In 2022, the North American region acquired around 37.8% share in the genitourinary prosthetics market.
According to the USA Department of Health and Human Services, approximately 30 million men in the USA are affected by it, which ultimately leads to depression, anxiety, and unsatisfied life. Urologists and healthcare professionals prefer penile prosthetics to treat erectile dysfunction and improve the patient's quality of life.
As a result of the rising recurrence of erectile dysfunction and infectious disease, the clamor for genitourinary prosthetics is increasing, resulting in increased revenue generation in the global genitourinary prosthetics market. There are several risk factors for developing erectile dysfunction that will enhance the demand in the North American genitourinary prosthetics market.
| Country | United States |
|---|---|
| 2022 Value Share in Global Market | 34.4% |
| Growth Factors | The United States genitourinary prosthetics market has witnessed significant growth in recent years. The United States has a rapidly aging population, leading to an increased prevalence of genitourinary disorders. As the elderly population grows, there is a higher demand for genitourinary prosthetics, particularly for conditions like erectile dysfunction and urinary incontinence. The shifting demographic pattern offers a substantial opportunities for market growth. |
Following North America, Europe has the largest profitability share in the global genitourinary prosthetics market, owing to the rising demand for genitourinary prosthetics and the availability of advanced technology in genitourinary prosthetic devices. However, Western Europe is poised to increase slowly in the global genitourinary prosthetics market in the coming years.
In 2019, approximately 32.3 million adults in the European Union were diagnosed with diabetes. Chronic Kidney Disease affects an estimated 75.1 million people in Europe. As a result of the rising incidence and mortality rates associated with diabetes and chronic kidney disease are projecting the genitourinary prosthetics market to grow speedily.
An alarmingly low level of awareness of erectile dysfunction has been observed in a European survey. A new survey commissioned by the European Association of Urology (EAU) has revealed that awareness of erectile dysfunction (ED) is alarmingly low in men aged 20 to 70.
As a result, the increasing prevalence of erectile dysfunction and infectious disease is propelling the growth of genitourinary prosthetics in Europe. In 2022, the Europe region acquired about 31.3% share in genitourinary prosthetics and is projected to maintain the governing growth throughout the forecast period, states Future Market Insights.
| Country | United Kingdom |
|---|---|
| 2022 Value Share in Global Market | 3.4% |
| Growth Factors | The United Kingdom genitourinary prosthetics market is witnessing steady growth. The United Kingdom's healthcare system, primarily driven by the National Health Service (NHS), plays a crucial role in shaping the genitourinary prosthetics market. NHS policies and reimbursement mechanisms heavily influence product adoption and market dynamics. The accessibility and affordability of genitourinary prosthetics under NHS programs are key factors affecting market growth. |
| Country | Germany |
|---|---|
| Value CAGR (2023 to 2033) | 6% |
| Growth Factors | Germany is one of the leading markets for genitourinary prosthetics in Europe. The market is primarily driven by factors such as a high prevalence of urological disorders, increasing awareness about available treatment options, and advancements in prosthetic technologies. Artificial urinary sphincters are gaining popularity in Germany for the treatment of urinary incontinence. The Germany genitourinary prosthetics market is expected to witness substantial growth in the coming years. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The genitourinary prosthetics market in Asia Pacific is expected to grow at a significant rate over the forecast period. Factors such as the increasing prevalence of genitourinary disorders, advancements in prosthetic technologies, and growing healthcare expenditure will drive market growth.
About 10% of Indian men suffer from impotence, with a potentially higher occurrence in metropolitan areas. Nearly a quarter of patients diagnosed with erectile dysfunction are under the age of 30, constituting 25 out of every 100 cases. Moreover, around 10% of the Indian population experiences chronic kidney disease (CKD), with more than one lakh cases of renal failure being reported each year.
Challenges related to limited reimbursement policies and high costs of advanced prosthetics need to be addressed. Continued research and development efforts, along with improved healthcare infrastructure, are likely to create lucrative opportunities for market players in the region.
| Country | China |
|---|---|
| Value CAGR (2023 to 2033) | 6% |
| Growth Factors | The China genitourinary prosthetics market has experienced substantial growth over the past few years and is expected to continue expanding at a steady rate. Growing awareness among the general population about genitourinary disorders and available treatment options has led to increased acceptance of genitourinary prosthetics in China. China has become a preferred destination for medical tourism due to its advanced healthcare infrastructure, skilled medical professionals, and relatively lower treatment costs. This has attracted patients from neighboring countries to seek genitourinary prosthetic procedures in China, thereby boosting the market. |
| Country | India |
|---|---|
| Value CAGR (2023 to 2033) | 4.9% |
| Growth Factors | The India genitourinary prosthetics market is poised for significant growth due to the increasing prevalence of genitourinary disorders, technological advancements, and rising healthcare expenditure. India has been witnessing a steady increase in healthcare expenditure. Government initiatives, such as the Ayushman Bharat program, have positively impacted the accessibility of healthcare services. The rise in healthcare spending has facilitated the affordability of genitourinary prosthetics and encouraged patients to opt for these devices. |
| Country | Japan |
|---|---|
| 2022 Value Share in Global Market | 3.9% |
| Growth Factors | Japan has one of the world's leading aging populations, leading to a higher prevalence of age-related urological conditions. This demographic trend presents a significant market opportunity for genitourinary prosthetics as older adults seek effective treatment options to address their urological disorders and maintain a high quality of life. The ongoing healthcare reforms, aimed at improving access to quality care and reducing healthcare costs, can influence the Japan genitourinary prosthetics market. |
| Segment | 2022 Value Share in Global Market |
|---|---|
| Silicon Material | 53.4% |
| Hospitals End User | 38.8% |
The dominance of the silicon material segment can be attributed to several factors. Silicon is widely used in the manufacturing of genitourinary prosthetics due to its biocompatibility, flexibility, durability, and soft tissue simulation properties. Its biocompatibility ensures that it is well-tolerated by the human body, minimizing the risk of adverse reactions. The flexibility of silicon allows for customization and shape to match the patient's anatomy, while its durability provides strength and stability to the prosthetic devices. Moreover, silicon closely resembles human tissue in terms of its softness and feel. Therefore, it enhances patient satisfaction and aesthetic outcomes. Additionally, silicon is waterproof and easy to clean, making it suitable for use in urinary systems. The established usage and safety record of silicon in medical devices also contributes to its dominance in the market.
The hospital end user segment dominates the market since they have specialized departments and clinics dedicated to urology and related specialties. They are also equipped with the necessary infrastructure and expertise for diagnosing and treating genitourinary conditions requiring prosthetic devices. Hospitals also provide a controlled and sterile environment required for complex surgical procedures involving genitourinary prosthetics, such as urinary incontinence and erectile dysfunction treatments. Additionally, the multidisciplinary approach often required for these conditions is readily available within hospital settings, allowing different specialists to collaborate and provide comprehensive care. Furthermore, hospitals are experienced in dealing with insurance providers and managing the reimbursement process, ensuring better patient access to costly prosthetic devices.
The swelling dispersion of start-ups in the Genitourinary Prosthetics industry has enhanced product quality and increased global sales. Besides, to gain a competitive edge, new start-ups are working on novel developments and launching new products such as:
Some of the leading players present in the global genitourinary prosthetics market are Boston Scientific Corporation, Zephyr Surgical Implants SÀRL, Coloplast Care, Promedon, UroMed, and others.
The key development in the Genitourinary Prosthetics market is as follows:
The North American region accounted for around 37.8% of the market.
Through 2033, the market is to develop at a CAGR of 4.8%.
By 2033, the market is to have expanded to USD 924.8 million.
In 2023, the market is anticipated to reach a worth of USD 577.9 million.
The global market evolved at a 3.5% HCAGR from 2018 to 2022.
With a market share of 53.4%, silicon dominates the market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.1. Genitourinary Prosthetic Devices 5.1.1. Catheter 5.1.2. Electronic Stimulator Device 5.1.3. Stent 5.2. Genitourinary Prosthetic Implants 5.2.1. Artificial Urinary Sphincter Implants (AUS) 5.2.2. Inflatable Penile Implant (IPP) Genitourinary Prosthetics 5.2.3. Testicular Prosthetic Implants 5.3. Genitourinary Prosthetic Grafts 5.3.1. Synthetic Mesh 5.3.2. Biological Mesh 5.3.3. Allograft 5.3.4. Xenograft 5.3.5. Suture Anchors 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type 6.1. Silicon 6.2. Titanium 6.3. Apatite 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Clinics 7.3. Rehabilitation Centers 7.4. Outpatient Surgical Centers 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Boston Scientific Corporation 18.2. Zephyr Surgical Implants SÀRL 18.3. Coloplast Care 18.4. Promedon 18.5. UroMed 18.6. Advin Healthcare 18.7. Qualigen Therapeutics, Inc. 18.8. Abbott 18.9. Rigicon Inc. 18.10. KARL STORZ GmbH and Co. KG 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Genitourinary Prosthetics Market
